Tag Archives: NASDAQ:CLBS

H.C. Wainwright Thinks Caladrius Biosciences’ Stock is Going to Recover

H.C. Wainwright analyst Ram Selvaraju reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS) today and set a price target of $7. The company’s shares closed yesterday at $3.13, close to its 52-week low of $2.63. According to TipRanks.com, Selvaraju

Caladrius Biosciences Gets a Buy Rating from H.C. Wainwright

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS), with a price target of $7. The company’s shares closed yesterday at $4.06. According to TipRanks.com, Selvaraju is ranked 0 out

Chardan Capital Thinks Caladrius Biosciences’ Stock is Going to Recover

Chardan Capital analyst Keay Nakae reiterated a Buy rating on Caladrius Biosciences (NASDAQ: CLBS) yesterday and set a price target of $6.50. The company’s shares closed yesterday at $3.76, close to its 52-week low of $3.26. According to TipRanks.com, Nakae